SectorPharmaceutical
Established Date19/01/2017
Listing Date08/01/2026
ExchangeNASDAQ Stock Exchange
Full-time Employees13
Fiscal Year Ends31/12
Security TypeCommon stock
Office address112-970 Burrard Street
Unit 1290
Vancouver
British Columbia
V6Z 2R4
Business
IntroductionNervGen Pharma Corp. was incorporated under the Business Corporations Act (British Columbia) on January 19, 2017. The company focuses on creating innovative solutions for the treatment of neurodegenerative and neurodegenerative diseases. The company is developing drugs to treat spinal cord injury, multiple sclerosis and Alzheimer's disease. The company is only engaged in a single business, namely drug research and development.
